Logo-ps
Pharm Sci. 2024;30(1): 54-69.
doi: 10.34172/PS.2023.24

Scopus ID: 85181571134
  Abstract View: 604
  PDF Download: 420

Review Article

Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art

Ishrat Zahoor 1 ORCID logo, Sukhbir Singh 1* ORCID logo, Neelam Sharma 1 ORCID logo, Ikmeet Kaur Grewal 2, Shahid Nazir Wani 3,4

1 Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India.
2 Department of Pharmacy, Government Medical College, Patiala, Punjab, India
3 Chitkara College of Pharmacy, Chitkara University, Rajpura Punjab, India.
4 Aman Pharmacy College, Dholakhera Udaipurwati, Jhunjhunu, Rajasthan, India.
*Corresponding Author: Email: singh.sukhbir12@gmail.com

Abstract

Hirsutism is characterized by the excessive growth of coarse hair in women, resembling the typical pattern seen in men. It affects between 5 to 10 % of females of reproductive age. Excessive hair growth often leads to significant mental and emotional anguish. Hirsutism is the result of an overabundance of androgens being secreted by the ovaries or adrenal glands. This article offers a comprehensive review of numerous causes that might provoke hirsutism which includes polycystic ovarian syndrome, Cushing syndrome, idiopathic hirsutism, insulin resistance, congenital adrenal hyperplasia, ovarian or adrenal tumors, menopause, and the use of certain drugs. Polycystic ovary syndrome and ovarian tumors are frequent underlying factors of hyperandrogenism, which subsequently results in the development of Hirsutism. Mechanical and cosmetic hair removal methods are viable options for managing hirsutism. This study examines the pharmacological therapies that have proven essential in enhancing the quality of life for patients. These treatments include oral contraceptives, antiandrogen therapy like spironolactone, cyproterone acetate, flutamide, and finasteride, specific insulin-lowering medicines, gonadotrophin-releasing hormone agonists, and topical treatment such eflornithine hydrochloride cream (13.9% w/w cream). This review also explored significance of nanotechnology-based methods like nanostructured lipid carriers, solid lipid nanoparticles, liposomes, cerosomes, and nanogel in enhancing the effectiveness of medications used to treat hirsutism. A comprehensive update has been made to the latest information on clinical studies and patents linked to the treatment of hirsutism.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 605

Your browser does not support the canvas element.


PDF Download: 420

Your browser does not support the canvas element.

Submitted: 31 Jul 2023
Revision: 27 Oct 2023
Accepted: 30 Oct 2023
ePublished: 13 Dec 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)